Yan-pei Zhang

1838 North Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumors.

Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumors.

Journal: Free radical biology & medicine
Published: October 06, 2025

CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.

CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.

Journal: Nature cancer
Published: December 05, 2024

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy.

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy.

Journal: Cancer cell
Published: June 21, 2024

HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.

HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.

Journal: BMC medicine
Published: March 08, 2024

Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases.

Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases.

Journal: Cancer research
Published: September 26, 2023

PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.

PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.

Journal: Cancer research
Published: May 26, 2022

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validation.

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validation.

Journal: BMC medicine
Published: April 14, 2022

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice.

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice.

Journal: BMC medicine
Published: December 04, 2021

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.

Journal: Nature communications
Published: September 17, 2021

Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies.

Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies.

Journal: Oncoimmunology
Published: May 17, 2021

De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.

De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.

Journal: Frontiers in oncology
Published: March 01, 2021

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.

Journal: EBioMedicine
Published: April 07, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026